부산대학교 도서관

To purchase or authenticate to the full-text of this article, please visit this link: http://dx.doi.org/10.1111/j.1525-1470.2006.00252.x Byline: Stephen Yoo (*), Soheil Simzar ([dagger]), Karen Han ([double dagger]), Stefani Takahashi (s.), Ronald Cotliar (s.) Abstract: Abstract: Erythrokeratoderma variabilis, also known as Mendes da Costa syndrome, is a genodermatosis belonging to the group of diseases known as the erythrokeratodermias. Erythrokeratoderma variabilis is characterized by two distinctive manifestations: well-demarcated, variable, transient, figurate patches of erythema, and localized or generalized hyperkeratotic plaques. Treatments include topical retinoic acid, salicylic acid, and alpha-hydroxy acid in petrolatum, but all have been reported to have limited, variable success rates. We report a child with erythrokeratoderma variabilis with no family history of this entity, successfully treated with topical tazarotene. Author Affiliation: (*)Department of Dermatology, University of Texas Southwestern, Dallas, Texas ([dagger])David Geffen School of Medicine at the University of California, Los Angeles, California ([double dagger])Department of Dermatology, Harbor-UCLA Medical Center, Torrance, California (s.)Division of Dermatology, University of California, Los Angeles, California Article note: Address correspondence to Stefani Takahashi, M.D., UCLA Med-Derm, Box 956957 Suite 450 200 Med Plaza, Los Angeles, CA 90095-6957, or e-mail: stakahashi@mednet.ucla.edu.